Bleeding in uremia.
D000227:Adenine Nucleotides / Q000494:pharmacology; D001241:Aspirin / Q000009:adverse effects; D001778:Blood Coagulation Disorders / Q000209:etiology; D001791:Blood Platelet Disorders / Q000139:chemically induced / Q000209:etiology; D002198:Capillary Fragility; D006470:Hemorrhage / Q000209:etiology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D010636:Phenols / Q000009:adverse effects; D010648:Phenylacetates / Q000009:adverse effects; D011517:Prothrombin Time; D006435:Renal Dialysis; D013386:Succinates / Q000009:adverse effects; D014511:Uremia / Q000150:complications*; D014652:Vascular Diseases / Q000150:complications
D000227:Adenine Nucleotides; D010636:Phenols; D010648:Phenylacetates; D013386:Succinates; D001241:Aspirin